Levels of pyrimethamine in sera and cerebrospinal and ventricular fluids from infants treated for congenital toxoplasmosis

Antimicrobial Agents and Chemotherapy

Volumn 36, Issue 5, 1992, Pages 1040-1048

  McLeod, R ^a   Mack, D ^a   Foss, R ^a   Boyer, K ^a   Withers, S ^a   Levin, S ^a   Hubbell, J ^a  

^a MICHAEL REESE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLINIC ACID; PHENOBARBITAL; PYRIMETHAMINE; SULFADIAZINE;

ANIMAL CELL; ARTICLE; BACTERIAL VIRULENCE; CLINICAL ARTICLE; CONGENITAL TOXOPLASMOSIS; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG HALF LIFE; HUMAN; INFANT; MOUSE; NEUTROPENIA; NEWBORN; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TOXOPLASMA GONDII;

EID: 0026751543     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.36.5.1040     Document Type: Article

References (0)